ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1929

Comparison of Two Different ANCA Iif Methods with EIA and Disease Phenotype

Pooja Bhadbhade1, Mehrdad Maz2, Lowell Tilzer3, Fred Plapp3 and Jason Springer1, 1Allergy, Clinical Immunology and Rheumatology, The University of Kansas Medical Center, Department of Internal Medicine, Division of Allergy, Clinical Immunology and Rheumatology, Kansas City, KS, 2Allergy, Clinical Immunology, and Rheumatology, The University of Kansas Medical Center, Department of Internal Medicine, Division of Allergy, Clinical Immunology and Rheumatology, Kansas City, KS, 3Pathology and Laboratory Medicine, The University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA, Churg-Strauss syndrome, Wegener's granulomatosis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Vasculitis - Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  ANCAs are used as diagnostic markers in patients with autoimmune vasculitis such as Granulomatosis with polyangitis (GPA), Microscopic polyangitis (MPA), and Eosinophilic granulomatosis with polyangitis (EGPA). Technique in laboratory testing for ANCAs differs among different centers. The purpose of this study is to compare two different techniques of IIF with enzyme immunoassay (EIA) and disease phenotype, specifically GPA.

Methods: Patient charts from a single tertiary medical center between August 2014 to August 2015 were retrospectively reviewed to identify occurrences in which two different methods of ANCA’s by IIF (method A and B) were completed as well as ANCA by EIA on the same day. Method A: IIF first screens samples on two slides, one with ethanol-fixed human neutrophils, and one with formalin-fixed human neutrophils, before determining the titer by ethanol fixation. Method B first performs automated EIA testing for MPO and PR3 antibodies (Abs) with a reflex to IIF if the MPO or PR3 Abs is equivocal or positive (> 0.4 U). Detection of ANCA is performed by IIF using slides coated with ethanol-fixed human neutrophils. Disease phenotype correlations were limited to GPA since c-ANCA and PR3 Abs are relatively specific for this disease. Correlations were determined by phi coefficient (Φ) and measures of significance determined by Fisher’s Exact Test.

Results: Fifty two patients had ANCA IIF testing done by two different established methods, A and B, on the same day. The correlation of c-ANCA by Method A IIF to PR3 Abs by EIA resulted in Φ of 0.609 (p = <0.0001) compared to Φ of 0.7025 (p<0.0001) when comparing Method B. The correlation of p-ANCA by method A IIF to MPO Abs by EIA resulted in Φ of 0.3578 (p=0.0166) compared to Φ of 0.4548 (p=0.0019) when comparing Method B. Correlation of c-ANCA by method A IIF to GPA disease phenotype resulted in a Φ of 0.2807 (p= 0.0945) compared with Φ of 0.3933 (p= 0.0101) when comparing Method B.

Conclusion:  When comparing two different ANCA testing methods, Method B, in which IIF is done only after a positive EIA and only with ethanol fixation, appears to have a stronger concordance with PR3 and MPO Abs as determined by EIA as well as disease phenotype. Limitations of this study included the small number of patients, and the technician dependent nature of IIF technique. A follow up study may consider using a larger number of patients.


Disclosure: P. Bhadbhade, None; M. Maz, None; L. Tilzer, None; F. Plapp, None; J. Springer, Vasculitis Foundation, 9,Genentech and Biogen IDEC Inc., 9.

To cite this abstract in AMA style:

Bhadbhade P, Maz M, Tilzer L, Plapp F, Springer J. Comparison of Two Different ANCA Iif Methods with EIA and Disease Phenotype [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/comparison-of-two-different-anca-iif-methods-with-eia-and-disease-phenotype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-two-different-anca-iif-methods-with-eia-and-disease-phenotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology